Efficacy and Safety,Long-term Study of Low-dose Oral Contraceptive Pill to Treat Dysmenorrhea.
Phase 3
Completed
- Conditions
- Dysmenorrhea
- Registration Number
- NCT00212277
- Lead Sponsor
- Nobelpharma
- Brief Summary
The purpose of this long-term study is to determine whether combination oral contraceptive pill of Norethindrone \& Ethinyl estradiol is effective in the treatmentof dysmenorrhea associated with endometriosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
- dysmenorrhea associated with endometriosis
Exclusion Criteria
- severe hepatopathy
- pregnant woman
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain norethindrone and ethinyl estradiol's efficacy in endometriosis-related dysmenorrhea?
How does low-dose OC pill compare to NSAIDs in managing endometriosis-associated dysmenorrhea long-term?
Are there specific biomarkers that predict response to low-dose oral contraceptives in endometriosis patients?
What are the potential adverse events of prolonged norethindrone/ethinyl estradiol use in dysmenorrhea treatment?
What combination therapies are being explored alongside low-dose OC pills for endometriosis management?